Clinical Trials Sponsored by Global Alliance for Improved Nutrition

Total 73 results

University of South Carolina
Global Alliance for Improved Nutrition

Completed

Impact Evaluation of GAIN Egg Campaign in Two Nigerian States

Egg Consumption

Nigeria
University of South Carolina
Global Alliance for Improved Nutrition

Completed

Complementary Feeding Project in Ethiopia

Egg Consumption

Ethiopia
Swiss Federal Institute of Technology
Global Alliance for Improved Nutrition; UNICEF

Withdrawn

RCT of Iodine-containing MNPs vs Oral Iodized Oil to Prevent Iodine Deficiency in Weaning Infants

Iodine Deficiency Disorders
University of Colorado, Denver
Temple University; Purdue University; Global Alliance for Improved Nutrition

Completed

The GAIN Study: Understanding What Helps Children Learn to Like and Eat New Foods

Parenting | Food Preferences

United States
North-West University, South Africa
Global Alliance for Improved Nutrition; Unilever R&D; DSM Ltd

Completed

Randomized Controlled Trial in South Africa Comparing the Efficacy of Complementary Food Products on Child Growth (TSWAKA)

Malnutrition

South Africa
University of California, Davis
Helen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance...

Completed

Impact of Targeted Zinc Fortification Programs on Plasma Zinc Concentration

Zinc Deficiency

Senegal
Swiss Federal Institute of Technology
Global Alliance for Improved Nutrition; United Nations World Food Programme...

Completed

Mineral Absorption From Fortified Rice Produced With Different Fortification Techniques

Iron Deficiency

Switzerland
University of Toronto
Emory University; University of California, Davis; Global Alliance for Improved... and other collaborators

Completed

Providing Peer Mother Support Through Cell Phone and Group Meetings to Increase Exclusive Breastfeeding in Kenya

Breastfeeding

Kenya
University of California, Davis
Helen Keller International; Cheikh Anta Diop University, Senegal; Global Alliance...

Completed

Impact of Mass Zinc Fortification Programs on Plasma Zinc Concentration

Zinc Deficiency

Senegal
Institut de Recherche pour le Developpement
Global Alliance for Improved Nutrition; National Institute of Nutrition, Vietnam and other collaborators

Completed

Efficacy of a Milk-based Nutrient-rich Bar on Nutritional Status and Cognitive Performance of School Children in Vietnam

Cognitive Performance

Vietnam
Centers for Disease Control and Prevention
Kenya Medical Research Institute; Global Alliance for Improved Nutrition; Safe...

Completed

Effectiveness of Selling Micronutrient Sprinkles in Rural Kenya (NICHE)

Anemia, Iron-deficiency

Kenya
Annamalai University
Johns Hopkins Bloomberg School of Public Health; Global Alliance for Improved... and other collaborators

Unknown

Efficacy of Micronutrient Fortified Yoghurt in School Children for Health Benefits

Child Development | Morbidity | Cognitive Development | Physical Growth

Bangladesh
Global Alliance for TB Drug Development

Recruiting

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis

Drug Sensitive Tuberculosis | Pulmonary Tuberculosis | Pulmonary TB

Philippines, South Africa, Tanzania, Georgia, Uganda
Global Alliance for TB Drug Development

Active, not recruiting

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis Volunteers (PaSEM)

Tuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Tuberculosis, MDR | Drug-Resistant Tuberculosis

Georgia, South Africa
Global Alliance for TB Drug Development

Completed

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis (ZeNix)

Tuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Extensively Drug-Resistant Tuberculosis | Tuberculosis, MDR | XDR-TB | Pre-XDR-TB

South Africa, Russian Federation, Georgia, Moldova, Republic of
Global Alliance for TB Drug Development

Completed

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis Infection

United States
Global Alliance for TB Drug Development

Completed

Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary | Pulmonary Disease | Multi Drug Resistant Tuberculosis | Drug Sensitive Tuberculosis | Drug-resistant Tuberculosis | Mycobacterium Tuberculosis Infection

United States
Global Alliance for TB Drug Development

Completed

A Phase 3 Study Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Subjects With Drug Resistant Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Global Alliance for TB Drug Development

Completed

Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam

Tuberculosis

United States
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

Tuberculosis

United States
Global Alliance for TB Drug Development

Completed

A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

Pulmonary Tuberculosis

South Africa
Global Alliance for TB Drug Development

Completed

PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis

Pulmonary Tuberculosis

South Africa
Global Alliance for TB Drug Development

Completed

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Tuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Tuberculosis, MDR | Drug-Resistant Tuberculosis

Tanzania, Georgia, Russian Federation, Brazil, Malaysia, Philippines, South Africa, Uganda
Global Alliance for TB Drug Development

Completed

Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects

Tuberculosis | Tuberculosis, Pulmonary

United States
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

Tuberculosis | Tuberculosis, Pulmonary

United States
Global Alliance for TB Drug Development

Completed

A Study in Two Panels of Healthy Adult Participants to Assess Single-Dose Immediate-Release and Single-Dose Dispersible Formulations of Pretomanid

Multi-drug Resistant Tuberculosis

United States
Global Alliance for TB Drug Development

Completed

Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009) (CL-009)

Tuberculosis

United States
Global Alliance for TB Drug Development

Completed

A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371

Tuberculosis | Tuberculosis, Pulmonary

United States
Global Alliance for TB Drug Development

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)

Pulmonary Tuberculosis

South Africa
Global Alliance for TB Drug Development

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z) (NC-003)

Pulmonary Tuberculosis

South Africa
Global Alliance for TB Drug Development

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)

Pulmonary Tuberculosis
Global Alliance for TB Drug Development

Terminated

A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects

Tuberculosis
Global Alliance for TB Drug Development

Completed

PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)

Tuberculosis

United States
Global Alliance for TB Drug Development

Completed

A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. (NC-005)

Tuberculosis

Tanzania, South Africa, Uganda
Global Alliance for TB Drug Development

Completed

Shortening Treatment by Advancing Novel Drugs (STAND)

Tuberculosis, Pulmonary, Drug Sensitive | Tuberculosis, Pulmonary, Multi Drug-resistant

South Africa, Zambia, Georgia, Philippines, Kenya, Malaysia, Tanzania, Uganda
Global Alliance for TB Drug Development

Completed

A Study of the Safety, Tolerability, and Absorption, Metabolism, and Excretion of PA-824 in Healthy Adult Male Subjects. (CL-004)

Tuberculosis

United States
Global Alliance for TB Drug Development

Completed

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Pulmonary Tuberculosis

Tanzania, South Africa
Global Alliance for TB Drug Development

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid

Tuberculosis | Tuberculosis, Pulmonary

United States
Global Alliance for TB Drug Development

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

Pulmonary Tuberculosis

South Africa
Global Alliance for TB Drug Development

Completed

Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-003)

Tuberculosis

United States
Regeneris Medical
Global Alliance for Regenerative Medicine

Recruiting

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata (SAAA)

Alopecia Areata | Scarring Alopecia

United States
Swiss Federal Institute of Technology
University of Zagreb; Global Alliance for Improved Nutrition; UNICEF; St. Luke's... and other collaborators

Completed

Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy (SIMPLIFY)

Iodine Deficiency

Philippines, Switzerland, China, Croatia
Healeon Medical Inc
Global Alliance for Regenerative Medicine

Suspended

Use of Stromal Vascular Fraction in Multiple Sclerosis (GARM-MS)

Multiple Sclerosis | Autoimmune

Honduras, United States
Healeon Medical Inc
Global Alliance for Regenerative Medicine

Withdrawn

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions (cSVF)

Multiple Sclerosis | Autoimmune

United States, Honduras
University of California, Davis
Bill and Melinda Gates Foundation; Penn State University; Newcastle University; Helen Keller International and other collaborators

Completed

Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children (GloVitAS-P)

Vitamin A Status

Philippines
Global Alliance for TB Drug Development
QPS Holdings LLC

Completed

Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults

Tuberculosis

Netherlands
University of California, Davis
United States Agency for International Development (USAID); Global Alliance... and other collaborators

Terminated

Dietary Intake, Health and Micronutrient Status in Haiti

Malnutrition | Chronic Disease | Malnutrition, Child | Micronutrient Deficiency

Haiti
Centers for Disease Control and Prevention
Bayer; Global Alliance for TB Drug Development

Completed

TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment

Tuberculosis

Uganda, United States, South Africa, Canada, Brazil, Spain
Robert W Alexander, MD
Regeneris Medical; Global Alliance for Regenerative Medicine

Unknown

Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease (BRT)

Osteoarthritis | Back Pain | Tendinopathy | Tendinosis | Degenerative Joint Disease | Rheumatoid Nodule

United States
The George Institute for Global Health, China
National Health and Medical Research Council, Australia; Global Alliance for...

Completed

SMARTHealth Diabetes in China Using Lay Family Health Promoters

Hypertension | Diabetes Mellitus, Type 2 | Dyslipidemias

China

Clinical Trials Sponsored by Global Alliance for Improved Nutrition

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations